1. |
Granero-Moltó F, Weis JA, Miga MI, et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells, 2009, 27(8): 1887-1898.
|
2. |
Falanga V. Wound healing and its impairment in the diabetic foot. Lancet, 2005, 366(9498): 1736-1743.
|
3. |
Misao Y, Takemura G, Arai M, et al. Bone marrow-derived myocyte-like cells and regulation of repair-related cytokines after bone marrow cell transplantation. Cardiovasc Res, 2006, 69(2): 476-490.
|
4. |
Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284(5411): 143-147.
|
5. |
Javazon EH, Keswani SG, Badillo AT, et al. Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells. Wound Repair Regen, 2007, 15(3): 350-359.
|
6. |
McFarlane RM, Deyoung G, Henry RA. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg, 1965, 35: 177-182.
|
7. |
Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient’s bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol, 2007, 211(1): 27-35.
|
8. |
邓蓉蓉, 谢伊旻, 谢林. 间充质干细胞归巢的研究与进展. 中国组织工程研究, 2016, 20(19): 2879-2888.
|
9. |
Liu N, Tian J, Cheng J, et al. Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney. J Cell Biochem, 2013, 114(12): 2677-2689.
|
10. |
Chiang KH, Cheng WL, Shih CM, et al. Statins, HMG-CoA reductase inhibitors, improve neovascularization by increasing the expression density of CXCR4 in endothelial progenitor cells. PLoS One, 2015, 10(8): e0136405.
|
11. |
Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med, 2004, 10(8): 858-864.
|
12. |
Oladipupo S, Hu S, Kovalski J, et al. VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting. Proc Natl Acad Sci U S A, 2011, 108(32): 13264-13269.
|
13. |
Hou Z, Nie C, Si Z, et al. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1α. Diabetes Res Clin Pract, 2013, 101(1): 62-71.
|
14. |
Mehrabani M, Najafi M, Kamarul T, et al. Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats. Cell Prolif, 2015, 48(5): 532-549.
|
15. |
Ikeda Y, Tajima S, Yoshida S, et al. Deferoxamine promotes angiogenesis via the activation of vascular endothelial cell function. Atherosclerosis, 2011, 215(2): 339-347.
|
16. |
Du Z, Zan T, Huang X, et al. DFO enhances the targeting of CD34-positive cells and improves neovascularization. Cell Transplant, 2015, 24(11): 2353-2366.
|
17. |
Ichioka S, Kudo S, Shibata M, et al. Bone marrow cell implantation improves flap viability after ischemia-reperfusion injury. Ann Plast Surg, 2004, 52(4): 414-418.
|
18. |
Zheng Y, Yi C, Xia W, et al. Mesenchymal stem cells transduced by vascular endothelial growth factor gene for ischemic random skin flaps. Plast Reconstr Surg, 2008, 121(1): 59-69.
|
19. |
Wu Y, Chen L, Scott PG, et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells, 2007, 25(10): 2648-2659.
|
20. |
Chen L, Tredget EE, Wu PY, et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One, 2008, 3(4): e1886.
|
21. |
Gnecchi M, He H, Noiseux N, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J, 2006, 20(6): 661-669.
|
22. |
Kinnaird T, Stabile E, Burnett MS, et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation, 2004, 109(12): 1543-1549.
|
23. |
Kinnaird T, Stabile E, Burnett MS, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res, 2004, 94(5): 678-685.
|